Neil MacLean
- Molecular Biology
- Oncology top 10%
- Hematology top 5%
- Cancer Research
- Immunology
- Co-authors
- Aaron D. SchimmerRose HurrenMarcela GrondaMark D. MindenAlessandro DattiTroy KetelaJason MoffatMahadeo A. Sukhai
- Topics
- Acute Myeloid Leukemia Research (17 papers)Protein Degradation and Inhibitors (11 papers)Ubiquitin and proteasome pathways (11 papers)
- Cited by
- HematologyCancer ResearchOncology
- Journals
- BloodPLoS ONECancer Research
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Neil MacLean
35 papers receiving 808 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 588
- Oncology 253
- Hematology 167
- Cancer Research 155
- Immunology 92
Countries citing papers authored by Neil MacLean
This map shows the geographic impact of Neil MacLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil MacLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil MacLean more than expected).
Fields of papers citing papers by Neil MacLean
This network shows the impact of papers produced by Neil MacLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil MacLean. The network helps show where Neil MacLean may publish in the future.
Co-authorship network of co-authors of Neil MacLean
This figure shows the co-authorship network connecting the top 25 collaborators of Neil MacLean. A scholar is included among the top collaborators of Neil MacLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil MacLean. Neil MacLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 103 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 20 | |
| 6 | 1 | |
| 7 | 17 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 13 | |
| 11 | 18 | |
| 12 | 40 | |
| 13 | 1 | |
| 14 | 33 | |
| 15 | 46 | |
| 16 | 19 | |
| 17 | 34 | |
| 18 | 1 | |
| 19 | 27 | |
| 20 | 56 |
About Neil MacLean
Neil MacLean is a scholar working on Hematology, Molecular Biology and Genetics, having authored 38 papers that have together received 816 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Protein Degradation and Inhibitors (11 papers) and Ubiquitin and proteasome pathways (11 papers). The work is most often cited by research in Hematology (167 citations), Cancer Research (155 citations) and Oncology (253 citations). Neil MacLean has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Aaron D. Schimmer, Rose Hurren, Marcela Gronda, Mark D. Minden, Alessandro Datti, Troy Ketela, Jason Moffat, Mahadeo A. Sukhai, Xinliang Mao and Xiaoming Wang. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.